Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

New China Life Insurance - H (1336.HK)

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date Stock Price (HK$) Price Target (HK$) Rating
2021-08-2021.9022.00Neutral
2021-08-2622.0521.00Neutral
2022-01-1722.5020.50Neutral
2022-04-2819.7819.40Neutral
2022-08-0418.3618.20Neutral
2023-01-1821.5024.20Neutral
2023-05-0322.1023.50Neutral
2023-10-3117.1417.80Neutral
2024-01-0514.8215.90Neutral
2024-03-2813.8614.40Neutral
2024-10-0926.0526.50Neutral

Disclosures

  • Within the past 12 months, UBS has received compensation for investment banking services from this company/entity or one of its affiliates.
  • UBS Securities Hong Kong Limited is a market maker in the Hong Kong-listed securities of this company.
  • Market capitalisation is calculated by multiplying the current share price by the sum of A and H shares.
  • UBS holds a long or short position of 0.5% or more of the listed shares of this company.
Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day.